MyFinsight
Home
Blog
About
Cash
$1,156,915
(199.77%↑ Y/Y)
Prepaid expenses and
other current assets
$211,969
(39.59%↑ Y/Y)
Total current assets
$1,368,884
(140.87%↑ Y/Y)
Operating lease
right-of-use asset
$102,549
(-31.69%↓ Y/Y)
Equipment and
furnishings, less...
$2,068
(-47.39%↓ Y/Y)
Accumulated deficit
-$265,126,832
(-1.82%↓ Y/Y)
Accumulated other
comprehensive loss
-$59,803
(0.92%↑ Y/Y)
Total assets
$1,473,501
(103.98%↑ Y/Y)
Total provectus
biopharmaceuticals, inc.,...
-$6,275,171
(-6.89%↓ Y/Y)
Non-controlling interest in
subsidiary
-$12,393
(-223.58%↓ Y/Y)
Additional paid-in capital
$258,475,479
(1.71%↑ Y/Y)
Common stock par value
0.001 per share...
$420,280
(0.00%↑ Y/Y)
Preferred stock
value-Series DOne...
$14,748
(7.46%↑ Y/Y)
Preferred stock
value-Series DConvertible...
$957
(0.00%↑ Y/Y)
Total liabilities and
stockholders deficit
$1,473,501
(103.98%↑ Y/Y)
Total stockholders
deficit
-$6,287,564
(-7.03%↓ Y/Y)
Total liabilities
$7,761,065
(17.64%↑ Y/Y)
Total current
liabilities
$7,707,145
(18.69%↑ Y/Y)
Operating lease
liability, non-current...
$53,920
(-48.10%↓ Y/Y)
Other accrued
expenses
$3,159,127
(20.42%↑ Y/Y)
Convertible notes
payable-Nonrelated Party
$2,075,000
(219.23%↑ Y/Y)
Convertible notes
payable-Related Party
$1,235,000
(-25.60%↓ Y/Y)
Accounts payable
$931,972
(-28.91%↓ Y/Y)
Accrued
interest-Related Party
$114,154
(-6.33%↓ Y/Y)
Notes payable
$92,443
(70.13%↑ Y/Y)
Operating lease
liability, current portion
$49,980
(8.11%↑ Y/Y)
Accrued
interest-Nonrelated Party
$49,469
(87.78%↑ Y/Y)
Back
Back
Balance Sheet
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT)
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT)
source: myfinsight.com